CTP510

General Information


DRACP ID  DRACP05301

Peptide Name   CTP510

Sequence  YGRRARRAARR

Sequence Length  11

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Fusion with beta-Gal

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C56H101N29O13

Absent amino acids  CDEFHIKLMNPQSTVW

Common amino acids  R

Mass  156714

Pl  12.8

Basic residues  6

Acidic residues  0

Hydrophobic residues  3

Net charge  6

Boman Index  -8329

Hydrophobicity  -211.82

Aliphatic Index  27.27

Half Life 
  Mammalian: 2.8 hour
  Yeast: 10 min
  E.coli: 2 min

Extinction Coefficient cystines  1490

Absorbance 280nm  149

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID US7101844B2

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  1731

DRACP is developed by Dr.Zheng's team.